Search
for
Sort by
Research 31–60 of 130
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Cutaneous manifestations of COVID-19: a systematic review and analysis of individual patient-level data
- The Dermatological Spectrum of Coronavirus Disease-19 Disease: Cutaneous Signs for Diagnostics and Prognosis and an Expanded Classification
- Adverse Cutaneous Reactions to Antidepressants
- Dermatology and Pregnancy
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- Cutaneous Drug Reaction Case Reports
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Skin manifestations associated with COVID-19
- Index
- Adverse Cutaneous Reactions to Mood Stabilizers
- Anticonvulsant-Induced Cutaneous Reactions
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- Adverse cutaneous effects of psychotropic medications
- Toxic shock syndrome: Recent developments in pathogenesis
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Physiologic changes and dermatoses of pregnancy
- REVIEW OF SO-CALLED ASEPTIC NEUTROPHILIC DERMATOSES
- Actinic superficial folliculitis
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Lupus erythematosus: systemic and cutaneous manifestations
- Dermatological adverse events with taxane chemotherapy
- Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease